Search Results - "A. J. Kormer"

PREDICTIVE SIGNIFICANCE OF ANTI-HLA AUTOANTIBODIES IN HEART TRANSPLANT RECIPIENTS by O. P. Shevchenko, T. A. Khalilulin, G. A. Olefirenko, R. M. Kurabekova, N. V. Apanasenko, A. O. Shevchenko, B. L. Mironkov, I. M. Ilyinsky, A. G. Kupriyanova, A. J. Kormer

“…Aim. The aim of this study was to define the role of preformed anti-HLA antibodies (anti-HLA) in antibody-mediated rejection (AMR) and cardiac allograft…”
Get full text

EFFECT OF CYTOMEGALOVIRUS INFECTION ON THE PREDICTIVE VALUE OF CD-40 LIGAND IN HEART TRANSPLANT RECIPIENTS by O. P. Shevchenko, T. A. Khalilulin, O. V. Orlova, E. N. Kazakov, A. J. Kormer, G. A. Oliferenko, V. V. Chestukhin, B. L. Mironkov, I. M. Ilyinsky, A. G. Kupriyanovа

“…Cytomegalovirus infection may be associated with the development of acute cellular rejection – the most fre- quent and serious complication after heart…”
Get full text

COMPARATIVE ANALYSIS OF SOLUBLE OF CD40 LIGAND LEVELS IN HEART RECIPIENTS TREATED WITH CYCLOSPORINE A AND TACROLIMUS by O. P. Shevchenko, T. A. Khalilulin, O. V. Orlova, E. N. Kazakov, A. J. Kormer, V. V. Сhestukhin, B. L. Mironkov

“…Soluble form of CD40L is platelet activating factor, which is a marker of inflammation and thrombosis. Elevated levels of sCD40L before the heart…”
Get full text

INDICATIONS FOR IMPLANTATION OF A PERMANENT DRIVER’S TRANSPLANTED HEART RHYTHM AND CHOICE OF A TREATMENT ELEKTROKARDIOSTIMULYATION by S. J. Shemakin, M. G. Lukava, A. J. Kormer

“…This report presents retrospective analysis of using artificial pacemaker in 16 heart transplanted patients because of developmented bradiarithmic disfunctions…”
Get full text

FEATURES OF CLINICAL DISPLAYS OF THE TRANSPLANTED HEART ACUTE REJECTION by S. J. Shemakin, A. J. Kormer, T. A. Khalilulin, V. V. Chestuhin, I. M. Iljinsky, A. G. Kuprijanova

“…In the present research features of current of clinical and structural changes are considered at acute rejection at the patients who have carried orthotopic…”
Get full text

METABOLIC AND AUTOIMMUNE RISK FACTORS FOR CORONARY ARTERY DISEASE (CAD) IN HEART TRANSPLANT RECIPIENTS by T. A. Khalilulin, O. V. Orlova, B. L. Mironkov, V. V. Chestuhin, E. N. Kazakov, A. J. Kormer, О. P. Shevchenko

“…One of the most essential autoimmunity risk factors for development of CAD are increasing level of anticardiolipin antibodies and homocystein. This report…”
Get full text

CLINICAL SIGNIFICATION OF MARKER OF NEOANGIOGENESIS PLACENTA GROWTH FACTOR PLGF IN HEART TRANSPLANT RECIPIENTS by О. P. Shevchenko, O. V. Orlova, S. El-Boustani, E. N. Kаzakov, A. J. Kormer

“…In transplanted hearts, peri- and postoperative ischemic and alloimmune stimuli may be interpreted as inadequate tissue perfusion leading to activation of…”
Get full text

PLACENTA GROWTH FACTOR IS ASSOCIATED WITH CARDIAC ALLOGRAFT VASCULOPATHY: 1151 by Shevchenko, O. P., Orlova, O. V., Kazakov, E. N., Kormer, A. J., Shevchenko, A. O.

Get full text

HOMOCYSTEIN, ANTI-CARDIOLIPIN ANTIBODIES AND SOLUBLE CD40 LIGAND IN HEART TRANSPLANT RECIPIENTS: 1137 by Orlova, O. V., Shevchenko, A. O., Kazakov, E. N., Kormer, A. J., Shevchenko, O. P.

Get full text